2nd Quarter - Report

PARENT PROJECT MUSCULAR DYSTROPHY for PARENT PROJECT MUSCULAR DYSTROPHY

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures/Biomedical Innovations; Patient-Focused Impact Assessment Act; PDUFA VI; American Health Care Act (AHCA)/Healthcare Repeal/Reform Appropriations Bill/Report Language; Better Care Reconciliation Act; BENEFIT Act, S. 1052

LobbyistCovered position, as disclosed
ANNIE KENNEDY —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); SENATE; Social Security Administration (SSA); Natl Institutes of Health (NIH)

Bills named: S. 1052 (115th)

Defense DEF

Congressionally Directed Medical Research Programs

LobbyistCovered position, as disclosed
ANNIE KENNEDY —

Contacted: Social Security Administration (SSA); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); SENATE; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Appropriations

LobbyistCovered position, as disclosed
ANNIE KENNEDY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); Food & Drug Administration (FDA); Social Security Administration (SSA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.